CANDEL 1.4.0

Generated by Alzabo

Enums

adverse-event.ae-causalityCausality attribution for adverse events.AE is causally related to drug/therapy., AE is not causally related to drug/therapy.
adverse-event.ctcae-gradeAdverse event grades per CTCAE v5.Grade 1 (mild)., Grade 2 (moderate)., Grade 3 (severe)....
analysis.typeThe type of analysis performed.Differential expression analysis., Differential methylation analysis., Pathway enrichment analysis....
assay.technologyEnumerates the supported assay experimental technologies.Quantitative PCR., Whole Genome Sequencing., DNA sequencing, unspecified type....
clinical-observation.borPartial Response., Unconfirmed Partial Response., Confirmed Partial Response....
clinical-observation.disease-stageEnumerates clinical disease/tumor stage.Stage III D., Stage I C., Stage I A....
clinical-observation.event-reasonReasons for survival event/censoring in clinical observations.Subject withdrew from study., Event status unknown., Censored for unknown reason....
clinical-observation.ir-recistImmune-related RECIST scores for solid tumor immune therapy response.Immune-related complete response., Immune-related partial response., Immune-related stable disease....
clinical-observation.ranoRANO (Response Assessment in Neuro-Oncology) categories.Partial response., Stable disease., Complete response....
clinical-observation.recistRECIST categories for clinical tumor response.Partial response., Progressive disease., Stable disease....
gene.hgnc-locus-groupGene locus group categories from HGNC.Protein-coding gene., Non-coding RNA gene., Pseudogene....
genomic-coordinate.assemblyGenome reference assembly.Genome Reference Consortium Human (GRCh37)., Genome Reference Consortium Human (GRCh38)., NCBI build 36....
measurement.cnv-callCopy number variant overall call.Copy number amplified segment., Copy number neutral segment., Copy number reduction segment.
measurement.msi-statusMicrosatellite instability status.Microsatellite stable (MSS)., Microsatellite instability – low (MSI-L)., Microsatellite instability – high (MSI-H).
moleculeThe major molecule/entity type.Gene molecule., Protein molecule.
sample.containerEnumerates the types of containers used for biospecimen collection.OMNIgene Gut fecal sample tube., Sodium citrate blood collection tube., PAXgene Blood DNA tube....
sample.lateralityLaterality of sample (in paired organs).Sample from both sides (bilateral)., Sample from left side., Sample from right side....
sample.specimenSample specimen types.Flash frozen tissue specimen., In vitro cell line., Serum specimen....
sample.tissue-acquisition-methodMethod by which tissue sample was acquired.Sample obtained by full surgical resection., Sample obtained by surgical biopsy., Ultrasound-guided biopsy....
sample.typeType of biological sample.Tumor tissue sample., Normal tissue sample., Abnormal (pathologic) non-tumor sample....
study-day.reference-eventReference event for study-relative day.Day of enrollment in the study., Day of diagnosis., Date of surgery.
subject.cause-of-deathCause of subject's death.Death related to cancer., Death unrelated to cancer.
subject.ethnicitySubject self-reported ethnicity.Subject identifies as hispanic or latino/a., Subject identifies as not hispanic or latino/a.
subject.raceSubject's self-reported race.White/Caucasian race., American Indian or Alaska Native., African-American or Black....
subject.sexSex assigned at birth for the subject.Female subject., Male subject., Sex unknown or not reported.
subject.smokerEnumerated subject smoking status.Former smoker., Current smoker., Never smoker.
therapy.previousThe type of previous therapy exposure for a subject.No prior therapy (treatment-naive)., Prior radiation therapy., Prior anti-PD-1 or anti-PD-L1 therapy....
timepoint.typeDefines the type of study timepoint.Baseline/pretreatment timepoint., Tumor assessment timepoint., Surgical intervention timepoint....
treatment-regimen.settingClinical setting for a treatment regimen.Neoadjuvant (pre-surgical) setting., Adjuvant (post-surgical) setting., Palliative care (symptom management).
variant.classificationFunctional classification of genomic variants.5' flanking sequence., 5' untranslated region., Splice site mutation....
variant.featureFeature type for genomic variants.A transcript region., A regulatory feature region., A nucleotide or protein motif.
variant.impactVariant functional impact classification.High predicted impact on function., Moderate impact., Low impact....
variant.typeThe type of sequence variant observed.Insertion., Deletion., Single Nucleotide Polymorphism....